RhumbLine Advisers’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$229K Buy
2025
Q2
$263K Buy
2025
Q1
$326K Sell
2024
Q4
$635K Buy
2024
Q3
$580K Sell
2024
Q2
$526K Buy
2024
Q1
$418K Buy
2023
Q4
$430K Buy
2023
Q3
$418K Buy
2023
Q2
$367K Buy